| Part Number : NDC00641-6045-25 | Manufacturer : West Ward Pharmaceutical Corp | ||
| NSN : 6505-01-411-2723 (6505014112723) | |||
| Item Name : Lorazepam Injection Usp | CAGE Code : 32655 | ||
| NIIN : 01-411-2723 (014112723) | |||
| INC Code : 50832 | |||
| NCB Code : 01 | Country : USA | ||
| Alternate P/N: NDC00641604525 | |||
Thank you for taking an interest in part number NDC00641-6045-25, that of which is listed with the description Lorazepam Injection Usp; Manufactured by West Ward Pharmaceutical Corp and listed alongside the NSN 6505014112723, part number NDC00641-6045-25 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
| Part Number : NDC00641-6045-25 | Manufacturer : West Ward Pharmaceutical Corp | ||
| NSN Number : 6505-01-411-2723 (6505014112723) | |||
| Item Name : Lorazepam Injection Usp | CAGE Code : 32655 | ||
| NIIN : 014112723 | |||
Thank you for taking an interest in part number NDC00641-6045-25, that of which is listed with the description Lorazepam Injection Usp; Manufactured by West Ward Pharmaceutical Corp and listed alongside the NSN 6505014112723, part number NDC00641-6045-25 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-411-2723 Item PartTypeName: LORAZEPAM INJECTION | 6505 | 014112723 | M | P | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| Q | A | |||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| NDC00641-6003-25 | 2 | 2 | 3 |
| MRC | Criteria | Characteristic |
|---|---|---|
| FEAT | Special Features | REFRIGERATION REQUIRED BETWEEN 2-8 DEGREES C. DEA CONTROLLED SUBSTANCE CLASS IV. |
| CXCY | Part Name Assigned By Controlling Agency | LORAZEPAM INJECTION 4MG/ML 1ML VIAL 25S PG |
| MRC | Decoded Requirement | Clear Text Reply |
| CRYC | Controlled Substance Classification | SCHEDULE IV |
| CRLK | Primary Container Content Quantity | 1.000 MILLILITERS |
| AKJA | Active Medicament Medicinal Strength | 4.000 MILLIGRAMS LORAZEPAM PER MILLILITER |
| CSCW | Total Primary Container Quantity | 25 |
| CQCT | Primary Container Type | VIAL |
| AJCN | Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote
